Safinamide Steady State Interaction With Rosuvastatin
Status:
Completed
Trial end date:
2017-07-06
Target enrollment:
Participant gender:
Summary
To evaluate if safinamide at the steady state, obtained after multiple 100 mg once a day
administrations, has an effect on the pharmacokinetics of rosuvastatin, concomitantly
administered as a single 20 mg dose, with respect to the pharmacokinetics of 20 mg
rosuvastatin administered alone.